Characterization and Properties of Nine Human Ovarian Adenocarcinoma Cell Lines

Cancer Research

Volumn 48, Issue 21, 1988, Pages 6166-6172

  Langdon, Simon P ^a   Lawrie, Sandra S ^a   Hay, Frances G ^a   Hawkes, Mary M ^a   McDonald, Amanda ^a   Hayward, Ian P ^a   Leonard, Robert C F ^a   Smyth, John F ^a   Schol, Dick J ^b   Hilgers, Jo ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENICITY; CELL CULTURE; CYTOCHEMISTRY; CYTOLOGY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; ANIMAL; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; FEMALE; HUMAN; MICE; MICE, INBRED CBA; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0023816378     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Richardson. G. S., Scully, R. E., Nikrui, N., and Nelson, J. H., Jr. Medical progress: Common epithelial cancer of the ovary. N. Engl. J. Med., 312: 415-424, 1985.
2. Rodenberg, C. J., and Cleton, F. G. Chemotherapy in advanced ovarian cancer. J. Cancer Clin. Oncol., 107: 99-105, 1984.
3. DiSaia, P. J., Morrow, M., Kanagus, J., Piechal, W., and Townsend, D. E. Two new tissue culture lines from ovarian cancer. Gynecol. Oncol., 3: 215-219, 1985.
4. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115-159. New York: Plenum Publishing Corp., 1975.
5. Hamilton, T. C., Young, R. C., McCoy, W. M., Grotinger, K. R., Green, J. A., Chu, E. W., Whang-Peng, J., Rogan, A. M., Green, W. R., and Ozols, R. F. Characterization of a human ovarian carcinoma cell line (NIH: OVCAR3) with androgen and estrogen receptors. Cancer Res., 43: 5379-5389, 1983.
6. Sinna, G. A., Beckman, G., Lundgren, E., Nordenson, I., and Roos, G. Characterisation of two new human ovarian carcinoma cell lines. Gynecol. Oncol., 7: 267-280, 1979.
7. Woods, L. K., Morgan, R. T., Quinn, L. A., Moore, G. E., Semple, T. U., and Stedman, K. E. Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res., 39: 4449-4459, 1979.
8. Kanabus. J., Braunstein. G. D., Emry, P. K., DiSaia, R. J., and Wade, M. E. Kinetics of growth and ectopie production of human chorionic gonadotropin by an ovarian cystadenocarcinoma cell line maintained in vitro. Cancer Res., 38: 765-770, 1978.
9. Benard. J., Da Silva, J., De Bois, M., Duvillard, P., Chiric, E., and Riou, G. Characterization of a human ovarian adenocarcinoma cell line, IG VORI, in tissue culture and in nude mice. Cancer Res., 45: 4970-4979, 1985.
10. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45: 3668-3676, 1985.
11. Freedman, R. S., Phil, E., Kusyk, C., Gallager, H. S., and Rutledge, F. Characterization of an ovarian carcinoma cell line. Cancer (Phila.). 42: 2352-2359, 1978.
12. Welander, C. E., Natale, R. B., and Lewis, J. L. In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages. J. Nati. Cancer Inst., 69: 1039-1047, 1982.
13. Van Haaften-Day, C., Russell, P., Rugg, C., Wills, E. J., and Tattersall, M. H. N. Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts. Cancer Res., 43: 3725-3731, 1983.
14. Simon, W. E., Albrecht, M., Hensel, M., Dietel, M., and Holzel, F. Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones. J. Nati. Cancer Inst., 70: 839-845, 1983.
15. Eva, A., Robbins, K. C., Andersen, P. R., Srinivasan, A., Tronick, S. R., Reddy, E. P., Ellmore, N. W., Galen, A. T., Lautenberger. J. A., Papas, T. S., Westin, E. H., Wong-Staal, F., Gallo, R. C., and Aaronson, S. A. Cellular genes analogous to retroviral one genes are transcribed in human tumor cells. Nature (Lond.), 295: 116-119, 1982.
16. Hill, B. T., Whelan, R. D. H., Gibby, E. M., Scheer, D., Hosking, L. K., Shellard, S. A., and Rupniak, T. H. Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int. J. Cancer, 39: 219-225, 1987.
17. Smith, A., Roberts, C., van Haaften-Day, C., den Dulk. G., Russel, P., and Tattersall, M. H. N. Cytogenetic findings in cell lines derived from four ovarian carcinomas. Cancer Genet. Cytogenet., 24: 231-242, 1987.
18. Bertoncello, I., Bradley. T. R., Webber, L. M., Hodgson, G. S., and Campbell, J. J. Human tumour cell lines established using clonal agar culture. Aust. J. Exp. Biol. Med. Sci., 63: 241-248, 1985.
19. Wilson, A. P. Characterization of a cell line derived from the ascites of a patient with papular) serous cystadenocarcinoma of the ovary. J. Nati. Cancer Inst., 72: 513-521, 1984.
20. Holzel, F., Albrecht, M., Simon, W. E., Hansel, M., Metz, R., Schweizer, J., and Dietel, M. Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture. J. Cancer Res. Clin. Oncol., 109: 217-226, 1985.
21. Clamon, G., Loh, P. M., White, M., and Robinson, R. Development and characterization of a human ovarian cancer cell line which clones without agar in vitro. Gynecol. Oncol., 20: 92-99, 1985.
22. Horowitz, A. T., Treves, A. J., Voss, R., Okon, E., Fuks, Z., Davidson, L., and Biran, S. A new human ovarian carcinoma cell line: Establishment and analysis of tumor-associated markers. Oncology, 42: 332-337, 1985.
23. Ishiwata, I., Ishiwata, C., Soma, M., Nazawa, S., and Ishikaka, H. Characterization of a newly established human ovarian carcinoma cell line-special reference of the effects of cis-platinum on cellular proliferation and release of CA 125. Gynecol. Oncol., 26: 340-354, 1987.
24. Filmus, J., Trent, J. M., Pullano, R., and Buick, R. N. A cell line from a human ovarian carcinoma with amplification of the K-ras gene. Cancer Res., 46: 5179-5182, 1986.
25. Wolf, C. R., Hayward, I. P., Lawrie, S. S., Buckton, K., McLntyre, M. A., Adams, D. J., Lewis, A. D., Scott, A. R. R., and Smyth, J. F. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int. J. Cancer, 39: 695-702, 1987.
26. Courtenay, V. D., Selby, P. J., Smith, I. E., Mills, J., and Peckham, M. J. Growth of human tumour cell colonies from biopsies using two soft agar techniques. Br. J. Cancer, 38: 77-81, 1978.
27. Steel, G. G., Courtenay, V. D., and Rostom, A. Y. Improved immunosuppression techniques for the xenografting of human tumours. Br. J. Cancer, 37: 224-230, 1978.
28. Bancroft, J. D. Enzyme histochemistry. In: J. D. Bancroft and A. Stevens (eds.), Theory and Practice of Histological Techniques, pp. 287-304. Edinburgh, London and New York: Churchill Livingstone, 1977.
29. Lillie, R. D., and Ashburn, L. L. Supersaturated solutions of fat stains indilute isopropanol for demonstration of acute fatty degeneration not shown by Herxheimer's technic. Arch. Pathol., 36: 432-435, 1943.
30. Cook, H. C. Carbohydrates. In: Theory and Practice of Histological Techniques, J. D. Bancroft and A. Stevens (eds.). pp. 141-167, Edinburgh, London and New York: Churchill Livingstone, 1977.
31. Sternberger, L. A. The unlabcllcd antibody (PAP) method. J. Histochem. Cytochem., 27: 1657-1659, 1979.
32. Schol, D. J., Mooi, W. J., van der Gugten, A. A., and Hilgers, J. Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int. J. Cancer, 2: 34-40, 1988.
33. Mooi, W. J., Wagenaar, S. S., Schol, D. J., and Hilgers. J. Monoclonal antibody 123C3: Its value in lung tumour classification. Mol. Cell Probes, 2: 31-37, 1988.
34. Raemaker, F. C. S., Puts, J. J. G., Moesker, O., Kant, A., Huysmans, A., Haag, D., Jap, P. H. K., Herman, C. J., and Vooijs, G. P. Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: An overview. Histochem. J., 15: 691-713, 1983.
35. Kabawat, S. E., Bast, R. C., Welch, W. R., Knapp, R. C., and Colvin, R. B. Immunopathologic characterisation of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors serous, endometrioid and clear cell types. Am. J. Clin. Pathol., 79: 98-104, 1983.
36. Magnani, J. L., Steplewski, Z., Koprowski, H., and Ginsburg, V. Identification of the gastrointestinal and pancreatic cancer associated antigen detected by monoclonal antibody 19/9 in the sera of patients as a mucin. Cancer Res., 43: 5489-5492, 1983.
37. Makin, C. A., Bobrow, L. G., and Bodmer, W. F. Monoclonal antibodies to cytokeratin for use in routine histopathology. J. Clin. Pathol., 37: 975-983, 1984.
38. Spurr, N. K., Durbin, H., Schear, D., Parkar, M., Bobrow, L., and Bodmer, W. F. Characterisation and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUA1. Int. J. Cancer, 38: 631-636, 1986.
39. Burchell, J., Durbin, H., and Taylor-Papadimitriou, J. Complexity of expression of antigenic determinants recognized by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant human mammary epithelial cells. J. Immunol., 131: 508-513, 1983.
40. Lane, E. B. Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organisation. J. Cell Biol., 92: 665-713, 1982.
41. Sunderland, C. A., Naiem, M., Mason, D. Y., Redman, C. W. G., and Stirrat, G. M. The expression of major histocompatibility antigens by human chorionic villi. J. Reprod. Immunol., 3: 323-331, 1981.
42. Travers, P., and Bodmer. W. Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human tropho blast-associated determinants. Int. J. Cancer, 33: 633-641. 1984.
43. Dexter, D. L., Lev, R., McKendall, G. R., Mitchell, P., and Calabresi, P. Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells. Histochem. J., 16: 137-149, 1984.
44. Buick, R. N. Cell heterogeneity in human ovarian carcinoma. J. Cell. Physiol. Suppl., 3: 117-122, 1984.
45. Bizzari, J. P., Mackillop, W. J., and Buick, R. N. Cellular specificity of NB70K. a putative human ovarian tumor antigen. Cancer Res., 43: 864-867, 1983.
46. Chung, Y. S., Song, I. S., Erickson, R. H., Sleisinger, M. H., and Kim, Y. S. Effect of growth and sodium butyrate on brush border membrane associated hydrolases in human colorectal cancer cell lines. Cancer Res., 45: 2976-2982, 1985.
47. Tsao, D., Morita, A., Bella, A., Jr., Luu, P., and Kim, Y. S. Differential effects of sodium butyrate, dimethyl sulphoxide, and retinoic acid on membrane-associated antigen, enzymes and glycoproteins of human rectal ade nocarcinoma cells. Cancer Res., 42: 1052-1058, 1982.
48. Reese, D. H., Gratzner, H. G., Block, N. L., and Politano, V. A. Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell. Cancer Res., 45: 2308-2313, 1985.
49. Reese, D. H., Gordon, B., Gratzner, H. G., Claflin, A. J., Malinin, T. I., Block, N. L., and Politano, V. A. Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphatase. Cancer Res., 43: 5443-5450, 1983.
50. Isaacs, J. T., Heston, W. D. W., Weissman, R. M., and Coffey, D. S. Animal models of the hormone-sensitive and-insensitive prostatic adenocarcinomas. Dunning R-3327-H. R-3327-HI, and R-3327-AT. Cancer Res., 38: 4353-4359, 1978.
51. Langdon, S. P., Hawkes, M. M., Hay, F. G., Lawrie, S. S., Schol, D. J., Hilgers, J., Leonard, R. C. F., and Smyth, J. F. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res., 48: 6161-6165, 1988.
52. Dhokia. B., Cannev, P. A., Pectasides, D., Munro, A. J., Moore, M., Wilkinson, P. M., Self, C. E., and Epenetos, A. A. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CAI25 for the serological detection and management of ovarian cancer. Br. J. Cancer, 54: 891-896, 1986.
53. McDicken, I. W., McLaughlin, P. J., Tromans, P. M., Luesley, D. M., and Johnson, P. M. Detection of placental-type alkaline phosphatase in ovarian cancer. Br. J. Cancer. 52: 59-64, 1985.
54. Nouwen, E. J., Rollet, D. E., Schelstraete, J. B., Eerdekens, M. W., Hansch, C., Van de Voorde, A., and De Broe, M. E. Human Placental alkaline phosphate in benign and malignant ovarin neoplasia. Cancer Res., 45: 892-902, 1985.
55. Bast, R.C., Klug, T.L., St. John, E., Jenison, E., Niloff, J.M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, T., Parker, L., Zurawski, V.R., and Knapp, R.C. A radiommunoassay using a monoclonal anti body to monitor the course of epithelial ovarian cancer. N. Eng. J. Med., 309: 883-887, 1983.